Olumide Martins
FDA investigator
Appears on 2 documents from 2024 to 2026, mostly at sites in Germany. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110).
- 2
- Documents on file
- 7.5
- Observations per 483
- 2024
- First seen
- 2026
- Most recent
What they cite most
From 15 observations- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.186Master production and control records1
- 21 CFR 211.25Personnel qualifications1
- 21 CFR 610.14Identity1
Activity by year
2024: 1, 2026: 1
Where
Germany 1 · Sweden 1
Often inspects with
Is Olumide Martins coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-03-27 | 483 Q-Med ABMar 27, 2026 · Uppsala, Sweden | Uppsala, Sweden | 11 | |
| 2024-03-19 | 483 Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Mooswiesen)Mar 19, 2024 · Ravensburg, Germany | Ravensburg, Germany | 4 |
About this profile
What does Olumide Martins inspect?
Olumide Martins appears on 2 documents on file covering 2 sites, mostly in Germany.
What do they cite most often?
21 CFR 211.110 (sampling and testing of in-process materials and drug products), followed by 21 CFR 211.113 and 21 CFR 211.186.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Olumide Martins is dated Mar 27, 2026.